Oral pharmacological treatment of X-linked dystonia parkinsonism: Successes and failures
Philippine Journal of Neurology
;
: 79-82, 2012.
Article
in English
| WPRIM
| ID: wpr-633183
ABSTRACT
There is a paucity of published literature on the different oral medications tried for X-linked dystonia parkinsonism (XDP). In practice, most XDP patients are tired on medication typically used for patients with generalized dystonia. These drugs include anticholinergic agents, baclofen, clonazepam and other ben-zodiazepines, tetrabenazine, and clozapine. Although several articles have shown that these classess of drugs are beneficial for patients with generalized dystonia, none been systematically studied specifically for XDP patients. We are currently conducting the first randomized, placebo-controlled trial on the medications that have been used in XDP.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Tetrabenazine
/
Baclofen
/
Levodopa
/
Clonazepam
/
Clozapine
/
Cholinergic Antagonists
/
Parkinsonian Disorders
/
Dystonic Disorders
/
Genetic Diseases, X-Linked
/
Dystonia
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
English
Journal:
Philippine Journal of Neurology
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS